Gitte Knudsen

Professor of Neurology at Copenhagen University Hospital

Data updated

Papers

28 publications

Trials

0 clinical trials

Research Footprint

Gitte Knudsen appears in 28 tracked papers (2011–2026), most studied alongside Psilocybin, LSD and MDMA, across Neuroimaging & Brain Measures, Healthy Volunteers and Depressive Disorders.

Most-cited paper: Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels (491 citations).

Frequent co-authors: Patrick Fisher, Dea Stenbæk and Mads Madsen.

Publication Landscape

How the 28 papers Blossom tracks for Gitte Knudsen line up by year, topic, and journal. These are the psychedelic-relevant papers in Blossom's records as of July 2026, not a complete bibliography.

How has Gitte Knudsen's publishing grown?

Sourced

Tracked papers by publication year; 1 earlier paper published before 2012. Click a year for the running total.

6papers published in 2022

+200% vs 2021

17 published by 2022

Browse papers

Don't read as total output: only the 28 of 28 tracked papers with a recorded publication date are counted, and these are the psychedelic-relevant papers Blossom tracks, not a complete bibliography. The current year is still filling in.

What does Gitte Knudsen publish on?

Sourced

Tracked papers per topic. Orange marks the largest research focus.

Don't read shares as adding to 100%: a paper tagged with several topics counts once per topic. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.

Where does Gitte Knudsen publish?

Sourced

Tracked papers per journal. Orange marks the most-used journal.

Counts the journal recorded on each tracked paper; preprints and papers with no journal on file are not shown. These are the psychedelic-relevant papers Blossom tracks, not a complete bibliography.

Background & Research

Gitte Moos Knudsen is a clinical neurologist and professor at the University of Copenhagen. As Director of NeuroPharm, she utilizes PET and fMRI to evaluate brain receptor occupancy and the functional impact of drugs. Her research in the psychedelic field explores how psilocybin modulates the serotonin system and brain connectivity to inform treatments for depression and neurological disorders.

Key Impact

Translational neurobiologist leading multi-modal imaging research on the serotonin system and psilocybin.

28

Research Papers

View publications →

0

Clinical Trials

Explore trials →

Collaboration Network

37 collaborators· click a node to visit their profile

Full network →

Collaboration Network

See Gitte Knudsen's full collaboration network, shared papers, and research connections.

Affiliations

Institutions, companies, and organisations Gitte Knudsen is associated with.